Drug recall
LORAZEPAM Tablets, USP, 0.5 mg, 90 tablets, Rx only, Manufactured for: Ranbaxy Pharmaceuticals Inc…
FDA recall event 57113 · Class II · Ranbaxy Pharmaceuticals, Inc.
Key facts
| Event ID | 57113 |
|---|---|
| Recall numbers | D-122-2011 |
| Recalling firm | Ranbaxy Pharmaceuticals, Inc. |
| Product type | Drugs |
| Products | LORAZEPAM Tablets, USP, 0.5 mg, 90 tablets, Rx only, Manufactured for: Ranbaxy Pharmaceuticals Inc. Jacksonville, FL 32257 USA; by: Ohm Laboratories Inc., North Brunswick, NJ 08902 USA; NDC… |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Adulterated Presence of Foreign Tablets: A foreign tablet was discovered during the dispensing/counting of the medication |
| Initiation date | Nov 2, 2010 |
| Termination date | Jan 23, 2012 |
| City | Princeton |
| State | NJ |
| Country | United States |
| FEI number | 3003476632 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports